Parathyroid Disease Treatment Global Market Report 2026

Description

Parathyroid disease treatment refers to medical and surgical interventions used to manage disorders of the parathyroid glands, which are small endocrine glands located in the neck that regulate calcium and phosphorus levels in the body through the secretion of parathyroid hormone (PTH).

The main types of parathyroid disease treatment include calcimimetics, bisphosphonates, plicamycin, hormone replacement therapy, and other therapies. Calcimimetics are drugs that lower PTH levels by mimicking calcium and activating calcium-sensing receptors on the parathyroid glands. These treatments are administered through various routes, including oral and parenteral, and are distributed via hospital pharmacies, retail pharmacies, and online pharmacies. They are used by a range of end users, including hospitals, homecare settings, specialty centers, and others.

Tariffs have impacted the parathyroid disease treatment market by increasing costs for imported active pharmaceutical ingredients (APIs) and medical devices used in parathyroid therapies. The resulting price surge is affecting segments such as calcimimetics, bisphosphonates, and parenteral administration, particularly in North America and Europe, where imports constitute a significant portion of the supply chain. Hospitals and specialty centers are most affected due to procurement dependence on global suppliers. However, tariffs are also encouraging local manufacturing and innovation, potentially reducing long-term dependency on imports and boosting domestic production capabilities.

The parathyroid disease treatment market research report is one of a series of new reports from The Business Research Company that provides parathyroid disease treatment market statistics, including parathyroid disease treatment industry global market size, regional shares, competitors with a parathyroid disease treatment market share, detailed parathyroid disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the parathyroid disease treatment industry. This parathyroid disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The parathyroid disease treatment market size has grown strongly in recent years. It will grow from $2.37 billion in 2025 to $2.54 billion in 2026 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to rising prevalence of hyperparathyroidism, limited awareness of parathyroid disorders, dependence on conventional hormone replacement therapy, lack of advanced surgical interventions, constrained hospital pharmacy infrastructure.

The parathyroid disease treatment market size is expected to see strong growth in the next few years. It will grow to $3.31 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to increasing demand for calcimimetics and bisphosphonates, advancements in parathyroid imaging and diagnostics, growing homecare and telemedicine solutions, regulatory support for precision medicine, expanding specialty centers for endocrine disorders. Major trends in the forecast period include increasing adoption of calcimimetics and bisphosphonates, rising preference for parenteral over oral administration in severe cases, expansion of hospital and specialty care settings, growing focus on personalized hormone replacement therapies, integration of lifestyle and nutritional interventions in treatment plans.

The rising prevalence of chronic kidney disease (CKD) is expected to drive growth in the parathyroid disease treatment market in the coming years. Chronic kidney disease is a long-term condition in which the kidneys gradually lose their ability to function properly, causing imbalances in essential minerals such as calcium and phosphorus. The increasing prevalence of CKD is largely attributed to the growing incidence of diabetes, as prolonged high blood sugar levels can damage the kidneys' filtering units over time, leading to diabetic nephropathy. Parathyroid disease treatments play a critical role in managing CKD by addressing secondary hyperparathyroidism, a common complication in advanced stages that disrupts calcium and phosphorus balance, contributes to bone disorders, and promotes vascular calcification. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that more than one in seven US adults-approximately 35.5 million people, or 14%-had CKD in 2023, and nearly 90% of them were unaware of their condition. Therefore, the rising prevalence of chronic kidney disease is propelling growth in the parathyroid disease treatment market.

Key companies in the parathyroid disease treatment market are focusing on developing innovative therapies such as parathyroid hormone (PTH) prodrugs to improve calcium regulation and reduce dosing frequency in patients with hypoparathyroidism. PTH prodrugs are inactive compounds that convert into active parathyroid hormone in the body to restore calcium and phosphate balance. For instance, in August 2024, Ascendis Pharma A/S, a Denmark-based biopharmaceutical company, received US Food and Drug Administration (FDA) approval for YORVIPATH (palopegteriparatide), a PTH [1-34] prodrug for treating chronic hypoparathyroidism in adults. This once-daily therapy provides continuous parathyroid hormone exposure over 24 hours, offering an alternative to conventional calcium and vitamin D supplementation by directly addressing the underlying hormone deficiency. The approval of YORVIPATH highlights the growing emphasis on advanced hormone replacement therapies designed to improve adherence and clinical outcomes for patients with parathyroid disorders.

In July 2024, AstraZeneca PLC, a UK-based biopharmaceutical company, acquired Amolyt Pharma SAS for $1.05 billion. Through this acquisition, AstraZeneca aims to strengthen its Alexion Rare Disease portfolio by advancing its late-stage pipeline and expanding its bone metabolism franchise with eneboparatide (AZP-3601), a Phase III investigational therapy for hypoparathyroidism. Amolyt Pharma SAS is a France-based clinical-stage biotechnology company developing novel treatments for rare endocrine diseases, including parathyroid disorders such as hypoparathyroidism.

Major companies operating in the parathyroid disease treatment market are AstraZeneca PLC, Amgen Inc., Kyowa Kirin Co. Ltd., OPKO Health Inc., Septerna Inc., Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., Crinetics Pharmaceuticals Inc., Vidasym Inc., Rani Therapeutics LLC, Pathalys Pharma Inc.

Asia-Pacific was the largest region in the parathyroid disease treatment market in 2025. The regions covered in the parathyroid disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the parathyroid disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The parathyroid disease treatment market consists of revenues earned by entities by providing services such as diagnostic testing, surgical intervention, hormone level monitoring, post-operative care, and medical management of calcium and phosphate balance. The market value includes the value of related goods sold by the service provider or included within the service offering. The parathyroid disease treatment market also includes sales of lanthanum carbonate, doxercalciferol, calcitriol, lanthanum carbonate, and parsabiv. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Parathyroid Disease Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses parathyroid disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for parathyroid disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The parathyroid disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Treatment: Calcimimetics; Bisphosphonates; Plicamycin; Hormone Replacement Therapy; Other Treatments
2) By Route Of Administration: Oral; Parenteral
3) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users
Subsegments:
1) By Calcimimetics: Cinacalcet; Etelcalcetide
2) By Bisphosphonates: Alendronate; Ibandronate; Risedronate; Zoledronic Acid
3) By Plicamycin: Mithramycin (Plicamycin) Monotherapy; Combination Therapies Involving Plicamycin
4) By Hormone Replacement Therapy: Estrogen Therapy; Progesterone Therapy; Combined Hormonal Therapies; Selective Estrogen Receptor Modulators (SERMs)
5) By Other Treatments: Parathyroid Hormone (PTH) Analogues; Surgery (Parathyroidectomy); Dietary Supplements; Lifestyle And Nutritional Interventions
Companies Mentioned: AstraZeneca PLC; Amgen Inc.; Kyowa Kirin Co. Ltd.; OPKO Health Inc.; Septerna Inc.; Entera Bio Ltd.; Visen Pharmaceuticals (Shanghai) Co. Ltd.; Ascendis Pharma A/S; Aeterna Zentaris Inc.; MBX Biosciences Inc.; Crinetics Pharmaceuticals Inc.; Vidasym Inc.; Rani Therapeutics LLC; Pathalys Pharma Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MPDTI04_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Parathyroid Disease Treatment Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Parathyroid Disease Treatment Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Parathyroid Disease Treatment Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Parathyroid Disease Treatment Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Industry 4.0 & Intelligent Manufacturing
- 4.1.4 Artificial Intelligence & Autonomous Intelligence
- 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Adoption Of Calcimimetics And Bisphosphonates
- 4.2.2 Rising Preference For Parenteral Over Oral Administration In Severe Cases
- 4.2.3 Expansion Of Hospital And Specialty Care Settings
- 4.2.4 Growing Focus On Personalized Hormone Replacement Therapies
- 4.2.5 Integration Of Lifestyle And Nutritional Interventions In Treatment Plans

5. Parathyroid Disease Treatment Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Homecare
5.3 Specialty Centers
5.4 Clinics
5.5 Diagnostic Laboratories

6. Parathyroid Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Parathyroid Disease Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Parathyroid Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Parathyroid Disease Treatment Market Size, Comparisons And Growth Rate Analysis
7.3. Global Parathyroid Disease Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Parathyroid Disease Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Parathyroid Disease Treatment Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Parathyroid Disease Treatment Market Segmentation

9.1. Global Parathyroid Disease Treatment Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Calcimimetics, Bisphosphonates, Plicamycin, Hormone Replacement Therapy, Other Treatments
9.2. Global Parathyroid Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Parenteral
9.3. Global Parathyroid Disease Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
9.4. Global Parathyroid Disease Treatment Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Homecare, Specialty Centers, Other End-Users
9.5. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Calcimimetics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Cinacalcet, Etelcalcetide
9.6. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Bisphosphonates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Alendronate, Ibandronate, Risedronate, Zoledronic Acid
9.7. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Plicamycin, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Mithramycin (Plicamycin) Monotherapy, Combination Therapies Involving Plicamycin
9.8. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Hormone Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Estrogen Therapy, Progesterone Therapy, Combined Hormonal Therapies, Selective Estrogen Receptor Modulators (SERMs)
9.9. Global Parathyroid Disease Treatment Market, Sub-Segmentation Of Other Treatments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Parathyroid Hormone (PTH) Analogues, Surgery (Parathyroidectomy), Dietary Supplements, Lifestyle And Nutritional Interventions

10. Parathyroid Disease Treatment Market Regional And Country Analysis

10.1. Global Parathyroid Disease Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Parathyroid Disease Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Parathyroid Disease Treatment Market

11.1. Asia-Pacific Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Parathyroid Disease Treatment Market

12.1. China Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Parathyroid Disease Treatment Market

13.1. India Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Parathyroid Disease Treatment Market

14.1. Japan Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Parathyroid Disease Treatment Market

15.1. Australia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Parathyroid Disease Treatment Market

16.1. Indonesia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Parathyroid Disease Treatment Market

17.1. South Korea Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Parathyroid Disease Treatment Market

18.1. Taiwan Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Parathyroid Disease Treatment Market

19.1. South East Asia Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Parathyroid Disease Treatment Market

20.1. Western Europe Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Parathyroid Disease Treatment Market

21.1. UK Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Parathyroid Disease Treatment Market

22.1. Germany Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Parathyroid Disease Treatment Market

23.1. France Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Parathyroid Disease Treatment Market

24.1. Italy Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Parathyroid Disease Treatment Market

25.1. Spain Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Parathyroid Disease Treatment Market

26.1. Eastern Europe Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Parathyroid Disease Treatment Market

27.1. Russia Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Parathyroid Disease Treatment Market

28.1. North America Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Parathyroid Disease Treatment Market

29.1. USA Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Parathyroid Disease Treatment Market

30.1. Canada Parathyroid Disease Treatment Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Parathyroid Disease Treatment Market

31.1. South America Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Parathyroid Disease Treatment Market

32.1. Brazil Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Parathyroid Disease Treatment Market

33.1. Middle East Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Parathyroid Disease Treatment Market

34.1. Africa Parathyroid Disease Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Parathyroid Disease Treatment Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Parathyroid Disease Treatment Market Regulatory and Investment Landscape

36. Parathyroid Disease Treatment Market Competitive Landscape And Company Profiles

36.1. Parathyroid Disease Treatment Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Parathyroid Disease Treatment Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Parathyroid Disease Treatment Market Company Profiles
- 36.3.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Kyowa Kirin Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. OPKO Health Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Septerna Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Parathyroid Disease Treatment Market Other Major And Innovative Companies

Entera Bio Ltd., Visen Pharmaceuticals (Shanghai) Co. Ltd., Ascendis Pharma A/S, Aeterna Zentaris Inc., MBX Biosciences Inc., Crinetics Pharmaceuticals Inc., Vidasym Inc., Rani Therapeutics LLC, Pathalys Pharma Inc.

38. Global Parathyroid Disease Treatment Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Parathyroid Disease Treatment Market

40. Parathyroid Disease Treatment Market High Potential Countries, Segments and Strategies

40.1 Parathyroid Disease Treatment Market In 2030 - Countries Offering Most New Opportunities
40.2 Parathyroid Disease Treatment Market In 2030 - Segments Offering Most New Opportunities
40.3 Parathyroid Disease Treatment Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer